Today: 19 June 2026
Browse Category

Earnings Reports 9 January 2026

Kroger maintained its 2026 outlook after first-quarter sales exceeded forecasts, but adjusted earnings missed estimates by a cent. Shares fell in premarket trading due to margin pressure from price investments, higher transport costs, and changes in fuel mix. CarMax reported fiscal Q1 revenue of $8.01 billion, beating forecasts, driven by higher used-car prices and strong wholesale demand, though retail used-vehicle gross profit per unit declined and the company continued price cuts to boost sales. La-Z-Boy shares rebounded nearly 17% in after-hours trading after adjusted earnings beat expectations, with revenue flat year-over-year; retail expansion supported results, but same-store orders and Joybird sales remained weak. Micron Technology shares dropped 3.6% after a record close as semiconductor stocks slipped, with investors locking in profits rather than reacting to specific company news. Netflix shares declined amid deal speculation involving Roku and Lionsgate, with the next earnings date set for July 16; the stock’s outlook depends on ads, pricing, and engagement. AT&T shares dipped 1.23% before a slight premarket uptick, underperforming the broader market as telecom stocks were influenced more by rate changes than company news; its Q2 earnings call is upcoming. Dave & Buster’s shares fell 4.72% after earnings missed on revenue, profit, and comps, raising questions about future sales and free-cash-flow targets. Nokia shares dropped 3.32% in Helsinki after a recent surge, with its ADR slightly up in New York; the company is set to report soon. Ford shares lagged the S&P 500, with the company seeking to continue importing China-built Lincoln Nautilus as new U.S. rules for connected-car software approach.
Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings

Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings

Arcutis Biotherapeutics shares fell 5.3% to $28.29 Friday after an early surge, tracking a shift in rate expectations following a soft U.S. jobs report. Broader biotech indexes rose. Investors are watching for Arcutis’ next earnings on Feb. 24 and an FDA decision on ZORYVE for children by June 29. The Fed’s late-January meeting remains a key focus for traders.
9 January 2026
···
Linde stock ticks up as Feb. 5 earnings date lands — what investors watch next

Linde stock ticks up as Feb. 5 earnings date lands — what investors watch next

Linde plc shares gained 1% to $444.18 Friday ahead of its fourth-quarter results due Feb. 5. The company previously forecast Q4 adjusted EPS below analyst estimates and reported a 3% drop in EMEA volumes, a trend expected to continue. Rival Air Products also rose. Investors await updates on demand and pricing as the S&P 500 hit a record high and materials stocks advanced.
9 January 2026
··
Nebius (NBIS) stock ticks up as AI names rebound — Rubin rollout and earnings are the next tests

Nebius (NBIS) stock ticks up as AI names rebound — Rubin rollout and earnings are the next tests

Nebius shares rose 1.2% to $98.48 Friday afternoon after swinging above $104 earlier in the session. The move followed gains in chip stocks and AI infrastructure names, with Nvidia up 0.5% and Applied Digital jumping over 17%. Traders are watching Nebius’ plans to offer Nvidia’s Rubin GPUs in late 2026 and its next earnings report, expected Feb. 18.
9 January 2026
··
Coca-Cola stock rises as soft U.S. jobs report boosts staples; CPI, Fed and earnings ahead

Coca-Cola stock rises as soft U.S. jobs report boosts staples; CPI, Fed and earnings ahead

Coca-Cola shares rose 1.4% to $70.33 Friday, topping $70 as investors favored consumer staples after a weaker-than-expected U.S. jobs report. Nonfarm payrolls increased by 50,000 in December, missing forecasts, while unemployment dipped to 4.4%. The Consumer Staples Select Sector SPDR Fund gained 0.9%. Markets await the December CPI report on Jan. 13 and the Fed’s policy meeting later this month.
9 January 2026
···
HealthEquity stock slides after Goldman Sachs downgrade; HQY earnings watch shifts to March

HealthEquity stock slides after Goldman Sachs downgrade; HQY earnings watch shifts to March

HealthEquity shares dropped 2.9% to $95.64 Friday after Goldman Sachs downgraded the stock to sell and set an $89 target. The move followed HealthEquity’s raised fiscal 2026 revenue outlook and a report of $34.4 billion in HSA assets. KeyBanc maintained an Overweight rating and lifted its price target to $125. The stock fell as the S&P 500 and Nasdaq 100 rose.
9 January 2026
···
P&G stock edges up after Crest kids toothpaste deal; TD Cowen trims target ahead of Jan. 22 earnings

P&G stock edges up after Crest kids toothpaste deal; TD Cowen trims target ahead of Jan. 22 earnings

Procter & Gamble agreed to change Kid’s Crest toothpaste packaging and marketing after pressure from Texas Attorney General Ken Paxton, who cited concerns over dosing for children. New labels began rolling out Jan. 1, with P&G required to comply for five years. Shares rose 0.3% to $141.92 Friday. A private lawsuit over Kid’s Crest labels remains active in Chicago.
9 January 2026
··
MakeMyTrip stock slides 4.5% in U.S. trade as investors turn to Jan. 22 earnings

MakeMyTrip stock slides 4.5% in U.S. trade as investors turn to Jan. 22 earnings

MakeMyTrip shares fell 4.5% to $78.78 in Friday afternoon trading, underperforming U.S.-listed travel peers. The stock hit a session high of $83.42 before sliding, with no new company updates ahead of its expected Jan. 22 earnings. Trading volume reached about 577,000 shares by mid-session. The drop puts MakeMyTrip near its lowest levels since early January.
9 January 2026
··
WD-40 stock slides 6% after Q1 profit falls; guidance held and Asia rebound in focus

WD-40 stock slides 6% after Q1 profit falls; guidance held and Asia rebound in focus

WD-40 shares dropped 5.6% to $192.13 after reporting a first-quarter profit decline and higher expenses, with the stock hitting a session low near $175. Net sales rose 1% to $154.4 million, but diluted EPS fell to $1.28 from $1.39. Management reaffirmed full-year guidance and blamed weak distributor markets for the profit slip. Investors await more detail at the Jan. 13 ICR Conference.
9 January 2026
··
Seagate (STX) stock rebounds toward $300 after Goldman target hike, earnings in focus

Seagate (STX) stock rebounds toward $300 after Goldman target hike, earnings in focus

Seagate Technology rose 5.4% to $299.92 after Goldman Sachs raised its price target to $310, citing strong 2026 pricing forecasts. The gain followed a 7.7% drop the previous day. A U.S. appeals court revived Seagate’s antitrust claims against NHK Spring late Thursday. Seagate’s next earnings report is expected around Jan. 20, though the date is unconfirmed.
9 January 2026
····
Citigroup stock ticks up as CPI, Citi earnings set next test

Citigroup stock ticks up as CPI, Citi earnings set next test

Citigroup shares gained 0.8% to $121.53 Friday as investors awaited next week’s U.S. bank earnings and December inflation data. Citigroup will report fourth-quarter results Wednesday, following JPMorgan’s release Tuesday. Analysts expect a 32% profit jump for Citi, citing stronger capital markets. The December Consumer Price Index is due Tuesday at 8:30 a.m. ET.
9 January 2026
··
Goldman Sachs stock edges up after Apple Card exit adds $0.46 to Q4 EPS — what to watch next

Goldman Sachs stock edges up after Apple Card exit adds $0.46 to Q4 EPS — what to watch next

Goldman Sachs shares rose 0.5% midday after confirming a deal to transfer the Apple Card program to JPMorgan Chase, moving over $20 billion in balances. The exit is expected to add $0.46 to Q4 EPS, with gains from loan-loss reserve releases offset by write-downs and contract costs. Investors await Goldman's Jan. 15 earnings for details on deal fees and trading. The Apple Card transition remains subject to regulatory approval.
9 January 2026
··
1 … 156 157 158 159 160 … 257

Stock Market Today

  • Green360 Technologies Unveils MKX Ultra Fine, Expands High-Strength Concrete Market Reach
    June 18, 2026, 8:54 PM EDT. Green360 Technologies (ASX:GT3) launched MKX Ultra Fine, a second metakaolin product that replaces silica fume one-for-one in high-strength concrete, confirmed independently by University of Melbourne to match strength specs. This expands Green360's commercial platform beyond its existing MKX Calcined Clay product targeting fly ash and slag replacement. Silica fume commands a premium price in niche markets for infrastructure-grade concrete, potentially improving Green360's margins and market value. The product addresses critical supply shortages caused by declines in fly ash, slag, and silica fume availability due to coal plant closures and reduced silicon metal production. The company now offers a versatile toolkit responding to a shrinking supplementary cementitious materials (SCM) supply, providing concrete producers essential alternatives for durable infrastructure.

Latest articles

Kardigan pops in first Nasdaq trading after $400 million IPO

Kardigan pops in first Nasdaq trading after $400 million IPO

19 June 2026
Kardigan surged 37.5% above its $16 IPO price to close at $22 after raising $400 million in an upsized Nasdaq debut, signaling renewed investor appetite for large biotech IPOs as the company advances three late-stage cardiovascular drug candidates.
Go toTop